" /> Anti-PTK7 Antibody-drug Conjugate SKB518 - CISMeF





Preferred Label : Anti-PTK7 Antibody-drug Conjugate SKB518;

NCIt synonyms : ADC SKB518; Anti-PTK7 ADC SKB518;

NCIt definition : An antibody-drug conjugate (ADC) composed of an antibody directed against human inactive tyrosine-protein kinase 7 (protein tyrosine kinase 7; PTK7) conjugated to a DNA topoisomerase I inhibitor, with potential antineoplastic activity. Upon administration of anti-PTK7 ADC SKB518, the anti-PTK7 antibody targets and binds to PTK7 expressed on tumor cells. Upon binding and internalization, the topoisomerase I inhibitor inhibits DNA topoisomerase I activity, thereby inhibiting DNA replication and resulting in DNA damage, cell cycle arrest and apoptosis in tumor cells overexpressing PTK7. In addition, this may cause a bystander effect, thereby further killing PTK7-expressing tumor cells. PTK7, a tumor-associated antigen (TAA), is overexpressed on a variety of cancer cells with limited expression in normal tissues. It is an integral player in cancer cell stemness and tumor progression.;

Molecule name : SKB 518; SKB-518;

Details


You can consult :


Nous contacter.
13/08/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.